Evidence map›Paper›PMID 21598261›Full record

ReviewThe Mount Sinai journal of medicine, New York

HIV care for geographically mobile populations.

Barbara S Taylor, L Sergio Garduño, Emily V Reyes, Raziel Valiño, Rita Rojas, Yeycy Donastorg, Karen Brudney, Jennifer Hirsch

Abstract readReview
In one paragraph

Review in The Mount Sinai journal of medicine, New York. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Mobility and HIV care engagement: a research agenda.Journal of the International AIDS Society · 2023
    Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Observational
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Barbara S TaylorUniversity of Texas Health Science Center at San Antonio, San Antonio, TX, USA. TaylorB4@uthscsa.edu
L Sergio Garduño
Emily V Reyes
Raziel Valiño
Rita Rojas
Yeycy Donastorg
Karen Brudney
Jennifer Hirsch

Funding

Columbia Population Research CenterR24HD058486 · NICHD · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI GARFINKEL, IRWIN · 2009 to 2013
$1.1M
The Impact of Mobility on HIV Care in New York City and the Dominican RepublicK23AI081538 · NIAID · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI TAYLOR, BARBARA S · 2009 to 2013
$645k
NIAID NIH HHS K23 AI081538NIAID NIH HHS K23AI081538NICHD NIH HHS R24 HD058486
6 · The paper itself

Abstract

The interaction between geographic mobility and risk for human immunodeficiency virus infection is well recognized, but what happens to those same individuals, once infected, as they transition to living with the infection? Does mobility affect their transition into medical care? If so, do mobile and nonmobile populations achieve similar success with antiretroviral treatment? The definition of mobility has changed over the centuries to encompass a complex phenotype including permanent migration, frequent travel, circular migration, and travel to and from treatment centers. The heterogeneity of these definitions leads to discordant findings. Investigations show that mobility has an impact on infection risk, but fewer data exist on the impact of geographic mobility on medical care and treatment outcomes. This review will examine existing data regarding the impact of geographic mobility on access to and maintenance in medical care and on adherence to antiretroviral therapy for those living with human immunodeficiency virus infection. It will also expand the concept of mobility to include data on the impact of the distance from residence to clinic on medical care and treatment adherence. Our conclusions are that the existing literature is limited by varying definitions of mobility and the inherent oversimplification necessary to apply a "mobility measure" in a statistical analysis. The impact of mobility on antiretroviral treatment outcomes deserves further exploration to both define the phenomenon and target interventions to these at-risk populations.

Indexed as

Emigration and ImmigrationGeographyAnti-HIV AgentsHealth Services AccessibilityHIV InfectionsHumansMedication AdherencePrevalenceRisk FactorsStatistics as TopicUnited StatesAnti-HIV Agents

Identifiers

PMID21598261
PMCPMC3100665

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.